{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T14:26:30Z","timestamp":1773757590957,"version":"3.50.1"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["neurology.org"],"crossmark-restriction":true},"short-container-title":["Neurology"],"published-print":{"date-parts":[[1996,10]]},"DOI":"10.1212\/wnl.47.4.1053","type":"journal-article","created":{"date-parts":[[2012,5,13]],"date-time":"2012-05-13T13:23:30Z","timestamp":1336915410000},"page":"1053-1059","update-policy":"https:\/\/doi.org\/10.1212\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":48,"title":["Evidence for a prolonged role of alpha sub 4 integrin throughout active experimental allergic encephalomyelitis"],"prefix":"10.1212","volume":"47","author":[{"given":"E.","family":"Keszthelyi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Karlik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Hyduk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.P.A.","family":"Rice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Yednock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Horner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"e_1_3_1_2_2","unstructured":"Gonzalez-Scarano F Speilman RS Nathanson N. Epidemiology. In: McDonald WI Silberberg DH eds. Multiple sclerosis. Boston: Butterworths 1986:37-55."},{"key":"e_1_3_1_3_2","doi-asserted-by":"crossref","unstructured":"Alvord C Jr Kies MW Suckling AJ eds. Experimental encephalomyelitis: a useful model for multiple sclerosis. New York: Liss 1984.","DOI":"10.1007\/978-1-4613-2403-4_3"},{"key":"e_1_3_1_4_2","unstructured":"Paterson PY. Autoimmune neurological diseases: experimental animal systems and implications for multiple sclerosis. In: Talal N ed. Autoimmunity: genetic immunologic virologic and clinical aspects. New York: Academic Press 1977:643-692."},{"key":"e_1_3_1_5_2","first-page":"2","volume":"5","year":"1991","unstructured":"Miller A, Hafler DA, Weiner HL. Tolerance and suppressor mechanisms in experimental autoimmune encephalomyelitis: implications for immunotherapy of human autoimmune diseases. FASEB J 1991;5:2560-2566.","journal-title":"FASEB J"},{"key":"e_1_3_1_6_2","first-page":"8","volume":"55","year":"1984","unstructured":"Paterson PY, Day ED, Whitacre CC. Neuroimmunologic diseases: effector cell responses and immunoregulatory mechanisms. Immunol Rev 1984;55:89-120.","journal-title":"Immunol Rev"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198207013070101"},{"key":"e_1_3_1_8_2","first-page":"6","volume":"50","year":"1984","unstructured":"Raine CS. Biology of disease. Analysis of autoimmune demyelination: its impact upon multiple sclerosis. Lab Invest 1984;50:608-635.","journal-title":"Lab Invest"},{"key":"e_1_3_1_9_2","first-page":"2","volume":"343","year":"1994","unstructured":"ffrench-Constant C. Pathogenesis of multiple sclerosis. Lancet 1994;343:271-275.","journal-title":"Lancet"},{"key":"e_1_3_1_10_2","first-page":"6","volume":"144","year":"1993","unstructured":"Butcher EC. Specificity of leukocyte-endothelial interactions and diapedesis: physiologic and therapeutic implications of an active decision process. Res Immunol 1993;144:695-698.","journal-title":"Res Immunol"},{"key":"e_1_3_1_11_2","first-page":"5","volume":"8","year":"1990","unstructured":"Zamvil SS, Steinman L. The T lymphocyte in experimental allergic encephalomyelitis. Ann Rev Immunol 1990;8:579-621.","journal-title":"Ann Rev Immunol"},{"key":"e_1_3_1_12_2","first-page":"1","volume":"136","year":"1990","unstructured":"Sobel RA, Mitchell ME, Fondren G. Intercellular adhesion molecule-1 (ICAM-1) in cellular immune reactions in the human central nervous system. Am J Pathol 1990;136:1309-1316.","journal-title":"Am J Pathol"},{"key":"e_1_3_1_13_2","first-page":"8","volume":"35","year":"1994","unstructured":"Washington R, Burton J, Todd RF, Newman W, Dragovic L, Dore-Duffy P. Expression of immunologically relevant endothelial cell activation antigens on isolated central nervous system microvessels from patients with multiple sclerosis. Ann Neurol 1994;35:89-97.","journal-title":"Ann Neurol"},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410370104"},{"key":"e_1_3_1_15_2","unstructured":"Pigott R Power C. The adhesion molecules facts book. San Diego: Academic Press 1993:176."},{"key":"e_1_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0955-0674(92)90052-E"},{"key":"e_1_3_1_17_2","first-page":"1","volume":"128","year":"1995","unstructured":"Alon R, Kassner PD, Woldemar Carr M, Finger EB, Hemler ME, Springer TA. The integrin VLA-4 supports tethering and rolling in flow in VCAM-1. J Biol Chem 1995;128:1243-1253.","journal-title":"J Biol Chem"},{"key":"e_1_3_1_18_2","first-page":"6","volume":"356","year":"1992","unstructured":"Yednock TA, Cannon C, Fritz LC, Sanchez-Madrid F, Steinman L, Karin N. Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha sub 4 beta sub 1 integrin. Nature 1992;356:63-66.","journal-title":"Nature"},{"key":"e_1_3_1_19_2","first-page":"5","volume":"177","year":"1993","unstructured":"Baron JL, Madri JA, Ruddle NH, Hashim G, Janeway CA Jr. Surface expression of alpha sub 4 integrin by CD4+ T cells is required for their entry into brain parenchyma. J Exp Med 1993;177:57-68.","journal-title":"J Exp Med"},{"key":"e_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-5728(94)00165-K"},{"key":"e_1_3_1_21_2","doi-asserted-by":"publisher","DOI":"10.1038\/256004a0"},{"key":"e_1_3_1_22_2","first-page":"5","volume":"5","year":"1995","unstructured":"Kent SJ, Karlik SJ, Rice GPA, Horner HC. A monoclonal antibody to alpha sub 4 integrin reverses the MRI-detectable signs of experimental allergic encephalomyelitis in the guinea pig. J Magn Reson Imaging 1995;5:535-540.","journal-title":"J Magn Reson Imaging"},{"key":"e_1_3_1_23_2","first-page":"3","volume":"30","year":"1991","unstructured":"Karlik SJ, Grant EA, Lee D, Noseworthy JH. Gadolinium enhancement in acute and chronic-progressive experimental allergic encephalomyelitis in the guinea pig. Magn Reson Med 1991;30:326-331.","journal-title":"Magn Reson Med"},{"key":"e_1_3_1_24_2","first-page":"1","volume":"137","year":"1990","unstructured":"Claudio L, Kress Y, Factor J, Brosnan CF. Mechanisms of edema formation in experimental allergic encephalomyelitis: the contribution of inflammatory cells. Am J Pathol 1990;137:1033-1045.","journal-title":"Am J Pathol"}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/WNL.47.4.1053","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T10:21:32Z","timestamp":1711534892000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.47.4.1053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,10]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1996,10]]}},"alternative-id":["10.1212\/WNL.47.4.1053"],"URL":"https:\/\/doi.org\/10.1212\/wnl.47.4.1053","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,10]]}}}